EBS Competitors & Alternatives

Compare Emergent Biosolutions Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

EBS

Main Stock
$8.28
Tradestie Score
57
Market Cap
$490.30M
Revenue Growth
-0.3%
Analyst Upside
+44.9%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
DVAX Dynavax Technologies Corporation
$15.50
$1.21B - 55 Compare
PCRX Pacira BioSciences, Inc. Common Stock
$25.39
$1.14B 192.5 57 Compare
COLL Collegium Pharmaceutical, Inc. Common Stock
$37.03
$1.11B 17.4 59 Compare
CRON Cronos Group Inc. Common Share
$2.86
$1.02B - 62 Compare
VIR Vir Biotechnology, Inc. Common Stock
$10.04
$791.82M - 57 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.18
$711.32M - 54 Compare
ESPR Esperion Therapeutics, Inc.
$3.16
$584.71M - 59 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$37.50
$543.32M - 57 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.33
$237.15M 6.6 60 Compare
BIOA BioAge Labs, Inc. Common Stock
$25.10
$212.23M - 55 Compare

Data updated: Jul 03, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry